BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22405807)

  • 1. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee.
    Allen AM; Pawlicki T; Dong L; Fourkal E; Buyyounouski M; Cengel K; Plastaras J; Bucci MK; Yock TI; Bonilla L; Price R; Harris EE; Konski AA
    Radiother Oncol; 2012 Apr; 103(1):8-11. PubMed ID: 22405807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton beam therapy].
    Ogino T
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):450-4. PubMed ID: 16612152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heavy charged particle radiotherapy--proton beam].
    Ogino T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy in pediatric oncology.
    Merchant TE
    Cancer J; 2009; 15(4):298-305. PubMed ID: 19672146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer.
    Efstathiou JA; Trofimov AV; Zietman AL
    Cancer J; 2009; 15(4):312-8. PubMed ID: 19672148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton-beam therapy for prostate cancer.
    Kagan AR; Schulz RJ
    Cancer J; 2010; 16(5):405-9. PubMed ID: 20890135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.
    Nihei K; Ogino T; Onozawa M; Murayama S; Fuji H; Murakami M; Hishikawa Y
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):390-6. PubMed ID: 20832180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    Verma V; Simone CB; Mishra MV
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
    Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
    Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018.
    Nogueira LM; Jemal A; Yabroff KR; Efstathiou JA
    JAMA Netw Open; 2022 Apr; 5(4):e229025. PubMed ID: 35476066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Verma V; Mishra MV; Mehta MP
    Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controversy over the Use of Proton Therapy for the Treatment of Tumors of Central Nervous System].
    Petera J
    Klin Onkol; 2017; 31(1):24-27. PubMed ID: 29488774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk.
    Efstathiou JA; Paly JJ; Lu HM; Athar BS; Moteabbed M; Niemierko A; Adams JA; Bekelman JE; Shipley WU; Zietman AL; Paganetti H
    Radiother Oncol; 2012 Apr; 103(1):12-7. PubMed ID: 22391053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
    Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
    Mishra MV; Aggarwal S; Bentzen SM; Knight N; Mehta MP; Regine WF
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):228-235. PubMed ID: 28068231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial.
    Bush DA; Kayali Z; Grove R; Slater JD
    Cancer; 2011 Jul; 117(13):3053-9. PubMed ID: 21264826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-beam therapy for tumors of the CNS.
    Gridley DS; Grover RS; Loredo LN; Wroe AJ; Slater JD
    Expert Rev Neurother; 2010 Feb; 10(2):319-30. PubMed ID: 20136386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.